Patent · US Active

Compositions and methods for treating proliferative disorders

US9447185B2 · kind B2 · utility

21Cited by
0References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 13, 2006
Grant dateSep 20, 2016
Priority date
Expiry dateApr 3, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to methods of treating proliferative disorders, particularly immunoproliferative and autoimmune disorders, and methods of producing antibodies which bind NK cell receptors for use in therapeutic strategies for treating such disorders, particularly to deplete cells involved in the immunoproliferative pathology.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.